Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research

1. Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms. They include a wide range of products derived from animals, humans or microorganisms by using biotechnology. Unlike other drugs, biologic products must remain constant by quality and purity throughout the process as they are highly sensitive to very minute changes during the process. Hence, it is very essential for the biological drugs to be manufactured in very controlled environment to ensure predictable outcomes. Moreover, biological drugs have aided in altering the treatment of many serious and chronic illnesses to a great extent. They are one of the most advanced therapies available and have the ability to treat cancer, ulcerative colitis, rheumatoid arthritis, and other autoimmune diseases. Global Biological Drugs Market Size and Forecast, 2015 - 2024 (US$ Billion) Growing elderly population, increasing prevalence of lifestyle and chronic diseases, and rising investments in various R&D programs are boosting the growth of the global biological drugs market. Moreover, government initiatives supporting the usage of biological drugs also drives the growth of the market. However, high costs of these drugs and possibility of adverse effects may hinder the growth of the market. Furthermore, technological advancements and cost reduction might provide significant scope for the market in future years. The global biological drugs market is categorized into product type and geography. By product type, the market is segmented into therapeutic protein (Enbrel, Lantus, Neulasta, Avones, Novolog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, Eylea And Others), monoclonal antibody (Humira, Remicade, Rituxan, Avastin, Herceptin, Lucentis, And Others) and vaccine (Prevnar 13, Gardasil, Fluzone, Varivax, Cervarix, And Others).

2. Global Biological Drugs market share by region, 2024 (value%) By geography, the market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers UK, Germany, France Italy, and others. Asia-Pacific covers China, Japan, India, South Korea, and others. RoW covers South America, Middle East, and Africa. They key companies operating in this market include Baxter International Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen Inc., Biogen Inc., GlaxoSmithKline Plc, Novartis AG, Eli Lilly and Co., Pfizer Inc., and Abbott Laboratories, among others. The key takeaways from the report • The report will provide a detailed analysis of Global Biological Drugs Market with respect to major segments such as product type and geography The report will include the qualitative and quantitative analysis with market estimation over 2015- 2024 and compound annual growth rate (CAGR) between 2016 and 2024 Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report An exhaustive regional analysis of Global Biological Drugs Market from 2015 to 2024 has been included in the report Profile of the key players in the Global Biological Drugs Market will be provided, which include key financials, product & services, new developments and business strategies • • • • Scope of the Global Biological Drugs Market Product Type Segments • Therapeutic Protein oEnbrel oLantus

3. oNeulasta oAvones oNovolog oRebif oHumalog oAranesp oEpogen oLevemir oVictoza oBetaseron oNeupogen oEylea oOther Therapeutic Proteins • Monoclonal Antibody oHumira oRemicade oRituxan oAvastin oHerceptin oLucentis oOther Monoclonal Antibodies • Vaccine oPrevnar 13 oGardasil oFluzone oVarivax oCervarix oOther Vaccines Geography Segments • North America oU.S. oCanada oMexico • Europe oUK oGermany oFrance oItaly oOthers • Asia-Pacific oIndia oChina

4. oJapan oSouth Korea oOthers RoW oSouth America oMiddle East oAfrica • Table of Content Chapter 1 Prefix 1.1 Market Scope 1.2 Report Description 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In-house Data Modeling Chapter 2 Executive Summary Chapter 3 Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Value Chain Analysis 3.4 Market Dynamics 3.4.1 Drivers 3.4.1.1 Impact Analysis 3.4.2 Restraints 3.4.2.1 Impact Analysis 3.4.3 Opportunities 3.5 Porter’s five forces analysis

5. 3.5.1 Factors Impact Analysis ….. Chapter 6 Company Profiles 6.1 Baxter International Inc. 6.2 Bristol-Myers Squibb Company 6.3 Merck & Co., Inc. 6.4 Amgen Inc. 6.5 Biogen Inc. 6.6 GlaxoSmithKline Plc 6.7 Novartis AG 6.8 Eli Lilly and Co. 6.9 Pfizer Inc. 6.10 Abbott Laboratories AboutVariant Market Research: Variant Market Research LLP was delineated in 2015 and to launch our business and website it grabbed more than a year. Our head office is based in Pune and we also have branch in San Francisco, California, the U.S. The long time was generally used to build up a talented team of experienced professionals and analysts, to generate client satisfying exact market analysis data. The company aims to be a specialist in delivering reports on various domains with precise analysis, keeping a virtuous relationship with our consumers. Our vision says, "We would like to grow with you, making your paths simpler yet solidest" and our mission is to "Implementing our analytical, technical and marketing skills to set a new goal for our consumers, dedicatedly helping them take their next strategic moves." The Co-founders of Variant Market Research: M/S ShwetaShubham and Mr. YogeshGodse are keen to provide services across aforementioned domains helping them to take their strategic moves regarding their business and providing them the growth opportunities. The Co-founders say, "We believe in providing the future solutions for your business, exploring the current market trends and suggesting you the future strategies and forecast of a particular market that could keep your company ahead in the competitive market rivalry." We hold expertise in our designated areas of research and consulting with a team of experts from each of the dedicated areas covered under our research. Destined by the dedicated

6. team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic move and take your company's future ahead with our support and your esteemed cooperation. For information, contact: VARIANT MARKET RESEARCH LLP Web: https://www.variantmarketresearch.com/ Address 649 Mission St.,5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com